Suppressor role of activating transcription factor 2 (ATF2) in skin cancer

Anindita Bhoumik, Boris Fichtman, Charles DeRossi, Wolfgang Breitwieser, Harriet M. Kluger, Sean Davis, Antonio Subtil, Paul Meltzer, Stan Krajewski, Nic Jones, Ze'ev Ronai

Research output: Contribution to journalArticlepeer-review

69 Scopus citations

Abstract

Activating transcription factor 2 (ATF2) regulates transcription in response to stress and growth factor stimuli. Here, we use a mouse model in which ATF2 was selectively deleted in keratinocytes. Crossing the conditionally expressed ATF2 mutant with K14-Cre mice (K14.ATF2f/f) resulted in selective expression of mutant ATF2 within the basal layer of the epidermis. When subjected to a two-stage skin carcinogenesis protocol [7,12-dimethylbenz[a] anthracene/phorbol 12-tetradecanoate 13-acetate (DMBA/TPA)], K14.ATF2 f/f mice showed significant increases in both the incidence and prevalence of papilloma development compared with the WT ATF2 mice. Consistent with these findings, keratinocytes of K14.ATF2f/f mice exhibit greater anchorage-independent growth compared with ATF2 WT keratinocytes. Papillomas of K14.ATF2f/f mice exhibit reduced expression of presenilin1, which is associated with enhanced β-catenin and cyclin D1, and reduced Notch1 expression. Significantly, a reduction of nuclear ATF2 and increased β-catenin expression were seen in samples of squamous and basal cell carcinoma, as opposed to normal skin. Our data reveal that loss of ATF2 transcriptional activity serves to promote skin tumor formation, thereby indicating a suppressor activity of ATF2 in skin tumor formation.

Original languageEnglish
Pages (from-to)1674-1679
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume105
Issue number5
DOIs
StatePublished - 5 Feb 2008
Externally publishedYes

Keywords

  • Cyclin D1
  • Keratinocyte
  • Papilloma
  • Presenilin
  • β-catenin

Fingerprint

Dive into the research topics of 'Suppressor role of activating transcription factor 2 (ATF2) in skin cancer'. Together they form a unique fingerprint.

Cite this